Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Brain Injuries | 76 | 2024 | 787 | 12.330 |
Why?
|
Brain Injuries, Traumatic | 50 | 2024 | 367 | 10.380 |
Why?
|
Brain Concussion | 19 | 2024 | 194 | 3.960 |
Why?
|
Cerebrovascular Circulation | 22 | 2017 | 471 | 3.900 |
Why?
|
Intracranial Hypertension | 18 | 2023 | 119 | 3.210 |
Why?
|
Erythropoietin | 10 | 2019 | 205 | 3.020 |
Why?
|
Intracranial Pressure | 17 | 2023 | 180 | 2.930 |
Why?
|
Glasgow Outcome Scale | 10 | 2023 | 47 | 2.730 |
Why?
|
Monitoring, Physiologic | 12 | 2023 | 502 | 1.850 |
Why?
|
Glasgow Coma Scale | 24 | 2023 | 215 | 1.770 |
Why?
|
Erythrocyte Transfusion | 4 | 2015 | 212 | 1.430 |
Why?
|
Critical Care | 11 | 2016 | 770 | 1.410 |
Why?
|
Recovery of Function | 10 | 2021 | 703 | 1.390 |
Why?
|
Biomarkers | 23 | 2024 | 5047 | 1.350 |
Why?
|
Brain | 19 | 2022 | 4113 | 1.290 |
Why?
|
Oxygen | 9 | 2020 | 754 | 1.190 |
Why?
|
Hemoglobins | 4 | 2019 | 477 | 1.120 |
Why?
|
Neuroprotective Agents | 5 | 2012 | 215 | 1.060 |
Why?
|
Glial Fibrillary Acidic Protein | 7 | 2023 | 151 | 1.050 |
Why?
|
Cerebral Cortex | 10 | 2016 | 621 | 1.050 |
Why?
|
Post-Concussion Syndrome | 3 | 2021 | 53 | 1.030 |
Why?
|
Hypothermia, Induced | 2 | 2016 | 170 | 0.990 |
Why?
|
Arginine | 7 | 2018 | 500 | 0.980 |
Why?
|
Microtubule-Associated Proteins | 3 | 2022 | 534 | 0.950 |
Why?
|
Nitric Oxide | 8 | 2018 | 644 | 0.940 |
Why?
|
Trauma Severity Indices | 4 | 2021 | 98 | 0.920 |
Why?
|
Disability Evaluation | 3 | 2021 | 249 | 0.860 |
Why?
|
Shock, Hemorrhagic | 2 | 2012 | 67 | 0.790 |
Why?
|
Microdialysis | 6 | 2015 | 50 | 0.750 |
Why?
|
Longitudinal Studies | 8 | 2023 | 1945 | 0.740 |
Why?
|
Adult | 73 | 2024 | 77950 | 0.740 |
Why?
|
Interleukin-10 | 2 | 2020 | 478 | 0.730 |
Why?
|
Injury Severity Score | 10 | 2020 | 237 | 0.730 |
Why?
|
Hemodynamics | 3 | 2015 | 935 | 0.720 |
Why?
|
Intracranial Hemorrhage, Traumatic | 3 | 2020 | 11 | 0.710 |
Why?
|
Humans | 126 | 2024 | 261506 | 0.710 |
Why?
|
Anemia | 3 | 2014 | 689 | 0.680 |
Why?
|
Cytokines | 3 | 2020 | 2809 | 0.680 |
Why?
|
Rats, Long-Evans | 10 | 2019 | 101 | 0.660 |
Why?
|
Brain Injuries, Diffuse | 1 | 2017 | 1 | 0.640 |
Why?
|
Brain Ischemia | 4 | 2004 | 292 | 0.630 |
Why?
|
Intensive Care Units | 2 | 2015 | 717 | 0.620 |
Why?
|
Rats | 21 | 2023 | 6086 | 0.620 |
Why?
|
Male | 82 | 2024 | 123000 | 0.600 |
Why?
|
Young Adult | 32 | 2022 | 21445 | 0.600 |
Why?
|
Blood Flow Velocity | 6 | 2010 | 475 | 0.600 |
Why?
|
Multiple Organ Failure | 1 | 2019 | 177 | 0.600 |
Why?
|
Interleukin-2 | 1 | 2020 | 842 | 0.580 |
Why?
|
Disease Models, Animal | 12 | 2018 | 7222 | 0.580 |
Why?
|
Markov Chains | 1 | 2017 | 175 | 0.580 |
Why?
|
Severity of Illness Index | 7 | 2021 | 4320 | 0.570 |
Why?
|
Prospective Studies | 27 | 2024 | 12873 | 0.560 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 2 | 2023 | 849 | 0.540 |
Why?
|
Middle Aged | 53 | 2022 | 86204 | 0.530 |
Why?
|
Arginase | 2 | 2018 | 48 | 0.520 |
Why?
|
Head Injuries, Closed | 4 | 2012 | 45 | 0.510 |
Why?
|
S100 Calcium Binding Protein beta Subunit | 1 | 2014 | 13 | 0.510 |
Why?
|
Models, Theoretical | 1 | 2019 | 785 | 0.500 |
Why?
|
Pulmonary Edema | 1 | 2015 | 80 | 0.500 |
Why?
|
Autonomic Nervous System Diseases | 1 | 2015 | 67 | 0.500 |
Why?
|
Endocrine System Diseases | 1 | 2015 | 83 | 0.490 |
Why?
|
Stress Disorders, Post-Traumatic | 4 | 2023 | 604 | 0.490 |
Why?
|
Female | 66 | 2024 | 141928 | 0.480 |
Why?
|
White Matter | 3 | 2022 | 195 | 0.480 |
Why?
|
Prognosis | 18 | 2023 | 21713 | 0.460 |
Why?
|
Craniocerebral Trauma | 2 | 2014 | 130 | 0.460 |
Why?
|
Nitric Oxide Synthase Type III | 3 | 2018 | 265 | 0.460 |
Why?
|
Animals | 43 | 2023 | 59536 | 0.460 |
Why?
|
Models, Cardiovascular | 2 | 2005 | 202 | 0.450 |
Why?
|
Oligopeptides | 2 | 2012 | 429 | 0.450 |
Why?
|
Myocytes, Smooth Muscle | 2 | 2005 | 198 | 0.450 |
Why?
|
Behavior, Animal | 2 | 2017 | 709 | 0.440 |
Why?
|
Neurophysiological Monitoring | 4 | 2016 | 23 | 0.430 |
Why?
|
Adolescent | 25 | 2022 | 31252 | 0.400 |
Why?
|
Antioxidants | 3 | 2023 | 507 | 0.400 |
Why?
|
Logistic Models | 3 | 2017 | 3441 | 0.400 |
Why?
|
Reaction Time | 1 | 2012 | 234 | 0.390 |
Why?
|
Alcoholic Intoxication | 1 | 2010 | 14 | 0.380 |
Why?
|
Disabled Persons | 2 | 2023 | 121 | 0.380 |
Why?
|
Blood Transfusion | 4 | 2019 | 583 | 0.380 |
Why?
|
Consciousness | 1 | 2010 | 56 | 0.370 |
Why?
|
Head Injuries, Penetrating | 2 | 2020 | 8 | 0.370 |
Why?
|
Spectroscopy, Near-Infrared | 1 | 2010 | 173 | 0.350 |
Why?
|
Magnetic Resonance Angiography | 1 | 2010 | 216 | 0.340 |
Why?
|
Cohort Studies | 12 | 2023 | 9244 | 0.340 |
Why?
|
Oxygen Consumption | 2 | 2008 | 401 | 0.340 |
Why?
|
Homeostasis | 4 | 2008 | 950 | 0.330 |
Why?
|
Models, Statistical | 1 | 2015 | 1171 | 0.330 |
Why?
|
Length of Stay | 1 | 2015 | 1900 | 0.330 |
Why?
|
Nitric Oxide Synthase | 3 | 2004 | 314 | 0.320 |
Why?
|
Hematoma, Subdural, Acute | 2 | 2004 | 12 | 0.310 |
Why?
|
Resilience, Psychological | 2 | 2022 | 64 | 0.310 |
Why?
|
Time Factors | 15 | 2021 | 12926 | 0.310 |
Why?
|
Decompressive Craniectomy | 2 | 2017 | 13 | 0.310 |
Why?
|
Neurosciences | 1 | 2008 | 53 | 0.310 |
Why?
|
Brain Chemistry | 2 | 2004 | 145 | 0.300 |
Why?
|
Critical Illness | 3 | 2008 | 714 | 0.300 |
Why?
|
Third-Party Consent | 1 | 2007 | 27 | 0.290 |
Why?
|
Oxygen Inhalation Therapy | 1 | 2008 | 119 | 0.290 |
Why?
|
Human Experimentation | 1 | 2007 | 51 | 0.290 |
Why?
|
Randomized Controlled Trials as Topic | 3 | 2023 | 2594 | 0.290 |
Why?
|
Trauma Centers | 7 | 2021 | 163 | 0.270 |
Why?
|
Ventriculostomy | 1 | 2006 | 34 | 0.270 |
Why?
|
Hyperoxia | 1 | 2008 | 133 | 0.270 |
Why?
|
Nonlinear Dynamics | 1 | 2005 | 78 | 0.270 |
Why?
|
Depressive Disorder, Major | 2 | 2023 | 441 | 0.260 |
Why?
|
Emergency Medical Services | 2 | 2007 | 429 | 0.260 |
Why?
|
Blood Pressure | 4 | 2005 | 1467 | 0.260 |
Why?
|
Cyclic GMP | 1 | 2005 | 116 | 0.250 |
Why?
|
Tomography, X-Ray Computed | 9 | 2021 | 7551 | 0.250 |
Why?
|
Deoxyguanosine | 1 | 2004 | 37 | 0.250 |
Why?
|
Olfactory Receptor Neurons | 1 | 2024 | 22 | 0.240 |
Why?
|
Receptors, Odorant | 1 | 2024 | 47 | 0.240 |
Why?
|
Mental Disorders | 1 | 2012 | 862 | 0.240 |
Why?
|
Cytidine Diphosphate Choline | 1 | 2023 | 5 | 0.240 |
Why?
|
Hippocampus | 5 | 2020 | 915 | 0.240 |
Why?
|
Oleic Acids | 1 | 2023 | 13 | 0.240 |
Why?
|
Aged | 24 | 2021 | 70117 | 0.230 |
Why?
|
Chlorambucil | 1 | 2023 | 26 | 0.230 |
Why?
|
Cerebral Arteries | 1 | 2003 | 73 | 0.230 |
Why?
|
Muscle, Smooth, Vascular | 1 | 2005 | 330 | 0.230 |
Why?
|
Ubiquitin Thiolesterase | 3 | 2022 | 216 | 0.220 |
Why?
|
Cerebral Infarction | 1 | 2003 | 59 | 0.220 |
Why?
|
Sarcoplasmic Reticulum | 1 | 2003 | 191 | 0.220 |
Why?
|
Free Radical Scavengers | 1 | 2003 | 80 | 0.220 |
Why?
|
Hemostasis | 1 | 2003 | 109 | 0.220 |
Why?
|
Muscle Contraction | 1 | 2003 | 218 | 0.220 |
Why?
|
Family | 1 | 2007 | 736 | 0.220 |
Why?
|
Carbon | 2 | 2023 | 149 | 0.220 |
Why?
|
Reference Values | 4 | 2015 | 1099 | 0.210 |
Why?
|
Telencephalon | 1 | 2002 | 11 | 0.210 |
Why?
|
Xenon | 2 | 2017 | 19 | 0.210 |
Why?
|
Calpain | 4 | 2022 | 64 | 0.210 |
Why?
|
Epilepsy, Post-Traumatic | 1 | 2021 | 12 | 0.210 |
Why?
|
Spinal Cord Injuries | 2 | 2022 | 374 | 0.210 |
Why?
|
Radiography | 5 | 2015 | 1904 | 0.210 |
Why?
|
Extracellular Vesicles | 1 | 2024 | 135 | 0.210 |
Why?
|
Neurologic Examination | 2 | 2014 | 245 | 0.210 |
Why?
|
Neurons | 7 | 2018 | 2287 | 0.200 |
Why?
|
Patient Acuity | 1 | 2021 | 72 | 0.200 |
Why?
|
Consciousness Disorders | 1 | 2021 | 34 | 0.200 |
Why?
|
Cardiovascular Diseases | 1 | 2015 | 2195 | 0.200 |
Why?
|
Sensitivity and Specificity | 6 | 2015 | 4971 | 0.200 |
Why?
|
Neuropsychological Tests | 3 | 2021 | 1178 | 0.190 |
Why?
|
C-Reactive Protein | 2 | 2022 | 527 | 0.190 |
Why?
|
Treatment Outcome | 13 | 2021 | 32848 | 0.190 |
Why?
|
Hyperthermia, Induced | 1 | 2005 | 510 | 0.190 |
Why?
|
Cysteine Proteases | 1 | 2020 | 7 | 0.190 |
Why?
|
Information Dissemination | 1 | 2023 | 272 | 0.190 |
Why?
|
Withholding Treatment | 2 | 2021 | 161 | 0.190 |
Why?
|
Computer Simulation | 3 | 2017 | 1529 | 0.190 |
Why?
|
Cathepsin B | 1 | 2020 | 32 | 0.190 |
Why?
|
Anesthesia | 1 | 2024 | 296 | 0.190 |
Why?
|
Aged, 80 and over | 11 | 2020 | 29902 | 0.180 |
Why?
|
Hydrocephalus | 2 | 2017 | 217 | 0.180 |
Why?
|
Astrocytes | 4 | 2022 | 368 | 0.180 |
Why?
|
Single-Blind Method | 1 | 2021 | 409 | 0.180 |
Why?
|
Cholesterol | 1 | 2023 | 658 | 0.180 |
Why?
|
Persistent Vegetative State | 2 | 2021 | 13 | 0.180 |
Why?
|
Proportional Hazards Models | 3 | 2017 | 4988 | 0.170 |
Why?
|
Body Fluids | 1 | 2020 | 125 | 0.170 |
Why?
|
Mice | 16 | 2023 | 34495 | 0.170 |
Why?
|
ROC Curve | 4 | 2016 | 1183 | 0.160 |
Why?
|
Follow-Up Studies | 7 | 2021 | 14889 | 0.160 |
Why?
|
Oxidative Stress | 2 | 2004 | 1129 | 0.160 |
Why?
|
Cognition | 2 | 2023 | 968 | 0.160 |
Why?
|
Interleukin-6 | 2 | 2016 | 1038 | 0.160 |
Why?
|
Patient Admission | 1 | 2019 | 220 | 0.150 |
Why?
|
Spatial Memory | 1 | 2017 | 41 | 0.150 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 4 | 2014 | 1489 | 0.150 |
Why?
|
Genetic Predisposition to Disease | 1 | 2011 | 5539 | 0.150 |
Why?
|
Life Support Care | 1 | 2017 | 50 | 0.150 |
Why?
|
Microglia | 2 | 2017 | 164 | 0.150 |
Why?
|
Proteolysis | 2 | 2021 | 370 | 0.150 |
Why?
|
Hypernatremia | 1 | 2017 | 33 | 0.150 |
Why?
|
rhoA GTP-Binding Protein | 1 | 2017 | 79 | 0.150 |
Why?
|
Nitric Oxide Synthase Type II | 3 | 2018 | 261 | 0.150 |
Why?
|
Spectrin | 2 | 2009 | 85 | 0.150 |
Why?
|
Caspase 3 | 3 | 2014 | 471 | 0.150 |
Why?
|
Retrospective Studies | 10 | 2024 | 37905 | 0.150 |
Why?
|
rho-Associated Kinases | 1 | 2017 | 85 | 0.150 |
Why?
|
Calcium | 1 | 2003 | 1537 | 0.150 |
Why?
|
Probability | 1 | 2019 | 866 | 0.150 |
Why?
|
Diffusion Tensor Imaging | 4 | 2022 | 303 | 0.150 |
Why?
|
Cerebrospinal Fluid Shunts | 1 | 2017 | 71 | 0.150 |
Why?
|
DNA Damage | 2 | 2004 | 1954 | 0.150 |
Why?
|
Likelihood Functions | 1 | 2017 | 233 | 0.140 |
Why?
|
Hypoxia, Brain | 1 | 2016 | 31 | 0.140 |
Why?
|
Maze Learning | 2 | 2017 | 132 | 0.140 |
Why?
|
Platelet Aggregation Inhibitors | 1 | 2020 | 444 | 0.140 |
Why?
|
Predictive Value of Tests | 6 | 2016 | 4892 | 0.140 |
Why?
|
Wounds, Nonpenetrating | 2 | 2012 | 176 | 0.140 |
Why?
|
Aftercare | 1 | 2018 | 259 | 0.140 |
Why?
|
Unconsciousness | 1 | 2016 | 21 | 0.140 |
Why?
|
Encephalitis | 1 | 2017 | 143 | 0.140 |
Why?
|
Sequence Analysis, RNA | 1 | 2020 | 651 | 0.140 |
Why?
|
Morbidity | 1 | 2017 | 397 | 0.140 |
Why?
|
Blood Gas Analysis | 2 | 2008 | 100 | 0.140 |
Why?
|
Motor Activity | 3 | 2017 | 693 | 0.140 |
Why?
|
Cognitive Dysfunction | 1 | 2021 | 333 | 0.140 |
Why?
|
Laser-Doppler Flowmetry | 3 | 2010 | 63 | 0.140 |
Why?
|
Algorithms | 4 | 2020 | 3890 | 0.130 |
Why?
|
Lateral Ventricles | 1 | 2015 | 26 | 0.130 |
Why?
|
Polyethylene Glycols | 1 | 2019 | 615 | 0.130 |
Why?
|
Consensus | 4 | 2023 | 978 | 0.130 |
Why?
|
Memory Disorders | 1 | 2017 | 295 | 0.130 |
Why?
|
Inflammation | 2 | 2023 | 2522 | 0.130 |
Why?
|
Anticoagulants | 1 | 2020 | 787 | 0.120 |
Why?
|
Nerve Fibers, Unmyelinated | 1 | 2014 | 15 | 0.120 |
Why?
|
Nanoparticles | 1 | 2019 | 554 | 0.120 |
Why?
|
Interleukin-8 | 1 | 2016 | 519 | 0.120 |
Why?
|
Subarachnoid Hemorrhage | 1 | 2014 | 95 | 0.120 |
Why?
|
Immunoassay | 1 | 2014 | 216 | 0.120 |
Why?
|
Cultural Diversity | 1 | 2014 | 76 | 0.120 |
Why?
|
Quality of Life | 3 | 2023 | 4532 | 0.120 |
Why?
|
Nerve Fibers, Myelinated | 1 | 2014 | 122 | 0.110 |
Why?
|
Rats, Sprague-Dawley | 5 | 2020 | 2063 | 0.110 |
Why?
|
Hypoxia-Ischemia, Brain | 1 | 2014 | 137 | 0.110 |
Why?
|
Thromboembolism | 1 | 2014 | 155 | 0.110 |
Why?
|
Wounds, Gunshot | 1 | 2014 | 102 | 0.110 |
Why?
|
Membrane Potentials | 2 | 2005 | 424 | 0.110 |
Why?
|
tau Proteins | 1 | 2014 | 216 | 0.110 |
Why?
|
Intracranial Hypotension | 1 | 2012 | 11 | 0.110 |
Why?
|
Area Under Curve | 1 | 2014 | 700 | 0.110 |
Why?
|
Partial Pressure | 1 | 2012 | 39 | 0.110 |
Why?
|
Nanotubes, Carbon | 1 | 2012 | 29 | 0.110 |
Why?
|
Vascular Resistance | 2 | 2003 | 200 | 0.110 |
Why?
|
Cross-Sectional Studies | 3 | 2017 | 4314 | 0.110 |
Why?
|
Research Design | 2 | 2022 | 1544 | 0.110 |
Why?
|
Superoxide Dismutase | 2 | 2023 | 266 | 0.100 |
Why?
|
I-kappa B Proteins | 1 | 2012 | 170 | 0.100 |
Why?
|
Hospital Mortality | 2 | 2015 | 1274 | 0.100 |
Why?
|
Axons | 1 | 2015 | 403 | 0.100 |
Why?
|
Fractures, Bone | 1 | 2014 | 291 | 0.100 |
Why?
|
Sagittal Sinus Thrombosis | 1 | 2011 | 4 | 0.100 |
Why?
|
Superior Sagittal Sinus | 1 | 2011 | 4 | 0.100 |
Why?
|
Multivariate Analysis | 2 | 2016 | 4298 | 0.100 |
Why?
|
Practice Guidelines as Topic | 2 | 2019 | 2403 | 0.100 |
Why?
|
Minority Groups | 1 | 2014 | 322 | 0.100 |
Why?
|
Acute Disease | 3 | 2020 | 2422 | 0.100 |
Why?
|
Cognition Disorders | 1 | 2017 | 786 | 0.100 |
Why?
|
Affect | 1 | 2013 | 288 | 0.100 |
Why?
|
Clinical Trials as Topic | 3 | 2015 | 3719 | 0.100 |
Why?
|
Skull Fractures | 1 | 2011 | 46 | 0.100 |
Why?
|
Neurophysins | 1 | 2010 | 4 | 0.100 |
Why?
|
Amyloid beta-Protein Precursor | 1 | 2011 | 137 | 0.100 |
Why?
|
Case-Control Studies | 6 | 2020 | 6100 | 0.100 |
Why?
|
Potassium Channels, Tandem Pore Domain | 1 | 2010 | 30 | 0.100 |
Why?
|
Brain Diseases | 1 | 2014 | 403 | 0.100 |
Why?
|
Infusions, Intravenous | 2 | 2004 | 1382 | 0.100 |
Why?
|
Vasopressins | 1 | 2010 | 62 | 0.090 |
Why?
|
Informed Consent | 1 | 2014 | 419 | 0.090 |
Why?
|
Ethanol | 1 | 2012 | 264 | 0.090 |
Why?
|
Image Interpretation, Computer-Assisted | 1 | 2014 | 592 | 0.090 |
Why?
|
Anxiety | 1 | 2017 | 1179 | 0.090 |
Why?
|
Random Allocation | 2 | 2019 | 703 | 0.090 |
Why?
|
Autoantibodies | 1 | 2014 | 576 | 0.090 |
Why?
|
Incidence | 2 | 2021 | 5673 | 0.090 |
Why?
|
Nervous System Diseases | 1 | 2014 | 500 | 0.090 |
Why?
|
Immunoglobulin G | 1 | 2014 | 1021 | 0.090 |
Why?
|
Brain Edema | 1 | 2010 | 86 | 0.090 |
Why?
|
Mice, Knockout | 4 | 2017 | 5710 | 0.090 |
Why?
|
Models, Biological | 3 | 2017 | 3254 | 0.090 |
Why?
|
Hypotension | 2 | 2019 | 210 | 0.090 |
Why?
|
Extracellular Fluid | 1 | 2008 | 19 | 0.090 |
Why?
|
Alcohol Drinking | 1 | 2012 | 551 | 0.090 |
Why?
|
Protein Precursors | 1 | 2010 | 240 | 0.090 |
Why?
|
United States | 6 | 2023 | 15433 | 0.080 |
Why?
|
Risk Factors | 4 | 2021 | 17523 | 0.080 |
Why?
|
Nerve Degeneration | 1 | 2009 | 148 | 0.080 |
Why?
|
Genotype | 2 | 2017 | 4109 | 0.080 |
Why?
|
Pulmonary Embolism | 1 | 2011 | 329 | 0.080 |
Why?
|
Hematoma, Subdural | 1 | 2007 | 28 | 0.080 |
Why?
|
Reproducibility of Results | 3 | 2014 | 6009 | 0.080 |
Why?
|
Intracranial Hemorrhages | 2 | 2021 | 121 | 0.080 |
Why?
|
Nerve Tissue Proteins | 2 | 2012 | 1491 | 0.080 |
Why?
|
Regional Blood Flow | 2 | 2010 | 276 | 0.080 |
Why?
|
Interleukin-1beta | 1 | 2008 | 300 | 0.070 |
Why?
|
Models, Animal | 2 | 2017 | 664 | 0.070 |
Why?
|
Neurosurgical Procedures | 1 | 2012 | 609 | 0.070 |
Why?
|
Observation | 1 | 2007 | 48 | 0.070 |
Why?
|
Cause of Death | 1 | 2010 | 752 | 0.070 |
Why?
|
Gene Expression Regulation | 2 | 2011 | 4053 | 0.070 |
Why?
|
MicroRNAs | 1 | 2020 | 2947 | 0.070 |
Why?
|
Patient Selection | 1 | 2014 | 2055 | 0.070 |
Why?
|
Ambulatory Care | 1 | 2010 | 554 | 0.070 |
Why?
|
Stroke | 1 | 2014 | 1144 | 0.070 |
Why?
|
Emergency Service, Hospital | 3 | 2019 | 1148 | 0.070 |
Why?
|
Peptides | 2 | 2022 | 1479 | 0.070 |
Why?
|
Magnetic Resonance Imaging | 3 | 2022 | 7702 | 0.070 |
Why?
|
Cerebral Ventricles | 1 | 2006 | 98 | 0.070 |
Why?
|
Muscle Relaxation | 1 | 2005 | 19 | 0.070 |
Why?
|
Potassium Channels, Calcium-Activated | 1 | 2005 | 13 | 0.070 |
Why?
|
Peptide Hydrolases | 2 | 2022 | 256 | 0.070 |
Why?
|
Electric Conductivity | 1 | 2005 | 94 | 0.070 |
Why?
|
Cerebral Hemorrhage, Traumatic | 1 | 2004 | 3 | 0.070 |
Why?
|
Mice, Inbred C57BL | 4 | 2015 | 6942 | 0.060 |
Why?
|
Dendrites | 2 | 2017 | 196 | 0.060 |
Why?
|
Feedback, Physiological | 1 | 2005 | 193 | 0.060 |
Why?
|
Texas | 1 | 2015 | 6311 | 0.060 |
Why?
|
DNA Fragmentation | 1 | 2004 | 198 | 0.060 |
Why?
|
Potassium Channels | 1 | 2005 | 162 | 0.060 |
Why?
|
Sodium Chloride | 1 | 2004 | 156 | 0.060 |
Why?
|
Viscosity | 1 | 2003 | 47 | 0.060 |
Why?
|
Dalteparin | 1 | 2003 | 13 | 0.060 |
Why?
|
Microfilament Proteins | 1 | 2007 | 487 | 0.060 |
Why?
|
Charcoal | 1 | 2023 | 8 | 0.060 |
Why?
|
Nitrates | 1 | 2003 | 43 | 0.060 |
Why?
|
Age Factors | 4 | 2017 | 5377 | 0.060 |
Why?
|
Elasticity | 1 | 2003 | 156 | 0.060 |
Why?
|
Risk Assessment | 4 | 2021 | 6869 | 0.060 |
Why?
|
Hematoma, Epidural, Cranial | 1 | 2003 | 11 | 0.060 |
Why?
|
Enoxaparin | 1 | 2003 | 66 | 0.060 |
Why?
|
Nitrites | 1 | 2003 | 61 | 0.060 |
Why?
|
Dominance, Cerebral | 1 | 2003 | 81 | 0.060 |
Why?
|
Catalase | 1 | 2003 | 70 | 0.060 |
Why?
|
Caspase 6 | 1 | 2022 | 15 | 0.060 |
Why?
|
Pyruvic Acid | 1 | 2004 | 133 | 0.060 |
Why?
|
Stress, Mechanical | 1 | 2003 | 311 | 0.050 |
Why?
|
Intermediate Filaments | 1 | 2022 | 27 | 0.050 |
Why?
|
Nitric Oxide Synthase Type I | 2 | 2018 | 53 | 0.050 |
Why?
|
Genetic Variation | 1 | 2011 | 2086 | 0.050 |
Why?
|
Drug Evaluation, Preclinical | 1 | 2004 | 503 | 0.050 |
Why?
|
Lactic Acid | 1 | 2004 | 305 | 0.050 |
Why?
|
Glutamic Acid | 1 | 2004 | 309 | 0.050 |
Why?
|
Catheterization, Central Venous | 1 | 2005 | 354 | 0.050 |
Why?
|
Neurogranin | 1 | 2021 | 2 | 0.050 |
Why?
|
Myelin Basic Protein | 1 | 2021 | 85 | 0.050 |
Why?
|
Postoperative Complications | 1 | 2017 | 5542 | 0.050 |
Why?
|
Cell Survival | 2 | 2010 | 3045 | 0.050 |
Why?
|
Hypoxia | 1 | 2004 | 443 | 0.050 |
Why?
|
Gene Expression Profiling | 2 | 2024 | 5159 | 0.050 |
Why?
|
Child | 4 | 2014 | 29154 | 0.050 |
Why?
|
Decision Making | 1 | 2009 | 1287 | 0.050 |
Why?
|
Patient Care Planning | 1 | 2023 | 297 | 0.050 |
Why?
|
Survival Rate | 4 | 2017 | 12221 | 0.050 |
Why?
|
DNA-Binding Proteins | 1 | 2014 | 4821 | 0.050 |
Why?
|
Cells, Cultured | 2 | 2014 | 5637 | 0.050 |
Why?
|
In Vitro Techniques | 1 | 2003 | 1618 | 0.050 |
Why?
|
Fibrinolytic Agents | 1 | 2003 | 324 | 0.050 |
Why?
|
Vimentin | 1 | 2021 | 253 | 0.050 |
Why?
|
Analysis of Variance | 1 | 2004 | 2307 | 0.050 |
Why?
|
Diffusion Magnetic Resonance Imaging | 1 | 2022 | 341 | 0.040 |
Why?
|
Venous Thrombosis | 1 | 2003 | 384 | 0.040 |
Why?
|
Consensus Development Conferences as Topic | 1 | 2019 | 75 | 0.040 |
Why?
|
Sex Distribution | 1 | 2021 | 495 | 0.040 |
Why?
|
Amygdala | 1 | 2020 | 127 | 0.040 |
Why?
|
Sepsis | 1 | 2005 | 652 | 0.040 |
Why?
|
Principal Component Analysis | 1 | 2020 | 218 | 0.040 |
Why?
|
Public Health | 1 | 2022 | 299 | 0.040 |
Why?
|
Tandem Mass Spectrometry | 1 | 2021 | 368 | 0.040 |
Why?
|
RNA | 1 | 2024 | 1013 | 0.040 |
Why?
|
Thy-1 Antigens | 1 | 2018 | 51 | 0.040 |
Why?
|
Carrier Proteins | 1 | 2007 | 2022 | 0.040 |
Why?
|
Pamphlets | 1 | 2018 | 31 | 0.040 |
Why?
|
Activities of Daily Living | 1 | 2021 | 552 | 0.040 |
Why?
|
Inpatients | 1 | 2023 | 678 | 0.040 |
Why?
|
Glucose | 1 | 2004 | 1248 | 0.040 |
Why?
|
Craniotomy | 1 | 2020 | 304 | 0.040 |
Why?
|
Gliosis | 1 | 2017 | 41 | 0.040 |
Why?
|
Self Report | 1 | 2021 | 756 | 0.040 |
Why?
|
Prosencephalon | 1 | 2017 | 43 | 0.040 |
Why?
|
Military Medicine | 1 | 2017 | 53 | 0.040 |
Why?
|
Propensity Score | 1 | 2020 | 750 | 0.040 |
Why?
|
Ultrasonography, Doppler, Transcranial | 1 | 2017 | 111 | 0.040 |
Why?
|
Disease Progression | 2 | 2020 | 6682 | 0.040 |
Why?
|
RNA, Messenger | 2 | 2024 | 6150 | 0.040 |
Why?
|
Resuscitation | 1 | 2019 | 223 | 0.040 |
Why?
|
Patient Care | 1 | 2017 | 149 | 0.040 |
Why?
|
Enzyme Activation | 1 | 2020 | 1764 | 0.040 |
Why?
|
Antibodies, Monoclonal | 2 | 2011 | 4367 | 0.040 |
Why?
|
Tissue Preservation | 1 | 2015 | 30 | 0.030 |
Why?
|
South America | 1 | 2015 | 52 | 0.030 |
Why?
|
Ultrasonography | 1 | 2002 | 1863 | 0.030 |
Why?
|
Gene Expression Regulation, Enzymologic | 1 | 2018 | 703 | 0.030 |
Why?
|
Infant | 1 | 2010 | 13310 | 0.030 |
Why?
|
Radiographic Image Enhancement | 1 | 2017 | 402 | 0.030 |
Why?
|
Adie Syndrome | 1 | 2014 | 4 | 0.030 |
Why?
|
Receptors, Chemokine | 1 | 2015 | 114 | 0.030 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2003 | 4938 | 0.030 |
Why?
|
Signal Transduction | 3 | 2020 | 11965 | 0.030 |
Why?
|
Chronic Disease | 1 | 2020 | 1819 | 0.030 |
Why?
|
Erythrocytes | 1 | 2015 | 339 | 0.030 |
Why?
|
Ankyrins | 1 | 2015 | 104 | 0.030 |
Why?
|
Child, Preschool | 1 | 2010 | 16273 | 0.030 |
Why?
|
Multicenter Studies as Topic | 1 | 2015 | 543 | 0.030 |
Why?
|
Oximetry | 1 | 2014 | 172 | 0.030 |
Why?
|
Postoperative Care | 1 | 2017 | 739 | 0.030 |
Why?
|
Benchmarking | 1 | 2015 | 273 | 0.030 |
Why?
|
Biomedical Research | 1 | 2020 | 806 | 0.030 |
Why?
|
Cerebrovascular Disorders | 1 | 2014 | 142 | 0.030 |
Why?
|
Immunoblotting | 1 | 2014 | 886 | 0.030 |
Why?
|
Hematinics | 1 | 2014 | 109 | 0.030 |
Why?
|
Clinical Protocols | 1 | 2015 | 467 | 0.030 |
Why?
|
Surveys and Questionnaires | 2 | 2021 | 5687 | 0.030 |
Why?
|
Anti-Bacterial Agents | 1 | 2005 | 2992 | 0.030 |
Why?
|
Macaca mulatta | 1 | 2015 | 717 | 0.030 |
Why?
|
Survival Analysis | 2 | 2017 | 9180 | 0.030 |
Why?
|
Comorbidity | 1 | 2019 | 2352 | 0.030 |
Why?
|
Gene Deletion | 1 | 2017 | 1442 | 0.030 |
Why?
|
Cell Death | 1 | 2014 | 671 | 0.030 |
Why?
|
Action Potentials | 1 | 2015 | 560 | 0.030 |
Why?
|
Registries | 1 | 2019 | 2170 | 0.030 |
Why?
|
Motorcycles | 1 | 2011 | 8 | 0.030 |
Why?
|
Extracellular Matrix | 1 | 2015 | 554 | 0.030 |
Why?
|
Receptors, Tumor Necrosis Factor | 1 | 2011 | 184 | 0.020 |
Why?
|
Blood-Brain Barrier | 1 | 2012 | 238 | 0.020 |
Why?
|
Prevalence | 1 | 2019 | 3260 | 0.020 |
Why?
|
Accidents, Traffic | 1 | 2011 | 116 | 0.020 |
Why?
|
Protein Stability | 1 | 2011 | 370 | 0.020 |
Why?
|
Cell Line | 1 | 2018 | 5114 | 0.020 |
Why?
|
Rabbits | 1 | 2011 | 957 | 0.020 |
Why?
|
Electroencephalography | 1 | 2014 | 898 | 0.020 |
Why?
|
Organ Specificity | 1 | 2011 | 699 | 0.020 |
Why?
|
Brain Mapping | 1 | 2014 | 644 | 0.020 |
Why?
|
Heart Arrest | 1 | 2014 | 358 | 0.020 |
Why?
|
Cell Count | 1 | 2010 | 508 | 0.020 |
Why?
|
Evidence-Based Medicine | 1 | 2015 | 1085 | 0.020 |
Why?
|
National Institutes of Health (U.S.) | 1 | 2010 | 208 | 0.020 |
Why?
|
Pupil | 1 | 2009 | 54 | 0.020 |
Why?
|
Recurrence | 1 | 2017 | 4758 | 0.020 |
Why?
|
Neurochemistry | 1 | 2008 | 6 | 0.020 |
Why?
|
Central Nervous System | 1 | 2011 | 436 | 0.020 |
Why?
|
Health Personnel | 1 | 2014 | 625 | 0.020 |
Why?
|
Odds Ratio | 1 | 2014 | 2316 | 0.020 |
Why?
|
Electrocardiography | 1 | 2014 | 1145 | 0.020 |
Why?
|
Societies, Medical | 1 | 2014 | 1335 | 0.020 |
Why?
|
Statistics, Nonparametric | 1 | 2010 | 980 | 0.020 |
Why?
|
Tumor Necrosis Factor-alpha | 1 | 2012 | 1538 | 0.020 |
Why?
|
Image Processing, Computer-Assisted | 1 | 2014 | 1648 | 0.020 |
Why?
|
Immunohistochemistry | 1 | 2017 | 7548 | 0.020 |
Why?
|
Silicones | 1 | 2005 | 54 | 0.020 |
Why?
|
NF-kappa B | 1 | 2012 | 1549 | 0.020 |
Why?
|
Sex Factors | 1 | 2010 | 2139 | 0.020 |
Why?
|
Phosphorylation | 1 | 2012 | 4804 | 0.020 |
Why?
|
Rifampin | 1 | 2005 | 191 | 0.020 |
Why?
|
Alzheimer Disease | 1 | 2011 | 855 | 0.010 |
Why?
|
Minocycline | 1 | 2005 | 182 | 0.010 |
Why?
|
Pia Mater | 1 | 2003 | 14 | 0.010 |
Why?
|
Arterioles | 1 | 2003 | 36 | 0.010 |
Why?
|
Expressed Sequence Tags | 1 | 2003 | 101 | 0.010 |
Why?
|
Prealbumin | 1 | 2003 | 37 | 0.010 |
Why?
|
Peptide Fragments | 1 | 2009 | 1271 | 0.010 |
Why?
|
Capillaries | 1 | 2003 | 99 | 0.010 |
Why?
|
Health Status Indicators | 1 | 2003 | 224 | 0.010 |
Why?
|
Nerve Growth Factor | 1 | 2002 | 45 | 0.010 |
Why?
|
Proto-Oncogene Proteins c-fos | 1 | 2002 | 123 | 0.010 |
Why?
|
Hormones | 1 | 2003 | 266 | 0.010 |
Why?
|
Calcium Signaling | 1 | 2003 | 284 | 0.010 |
Why?
|
Molecular Structure | 1 | 2002 | 515 | 0.010 |
Why?
|
Inflammation Mediators | 1 | 2003 | 423 | 0.010 |
Why?
|
Glycoproteins | 1 | 2003 | 747 | 0.010 |
Why?
|
Patient Compliance | 1 | 2003 | 667 | 0.010 |
Why?
|
Hemorrhage | 1 | 2003 | 712 | 0.010 |
Why?
|
Patient Satisfaction | 1 | 2003 | 915 | 0.010 |
Why?
|
Down-Regulation | 1 | 2003 | 2074 | 0.010 |
Why?
|
Oligonucleotide Array Sequence Analysis | 1 | 2003 | 2508 | 0.010 |
Why?
|
Up-Regulation | 1 | 2003 | 2450 | 0.010 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2003 | 3639 | 0.010 |
Why?
|
Mitochondria | 1 | 2003 | 1282 | 0.010 |
Why?
|